Northern Trust
NPCE icon

Northern Trust’s Neuropace NPCE Stock Holding History

Northern Trust’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.13M Buy
260,025
+20,185
+8% +$325K ﹤0.01% 2725
2026
Q1 		$3.15M Buy
239,840
+8,066
+3% +$121K ﹤0.01% 2711
2025
Q4 		$3.58M Sell
231,774
-4,677
-2% -$62.5K ﹤0.01% 2666
2025
Q3 		$2.44M Buy
236,451
+4,435
+2% +$41.8K ﹤0.01% 2922
2025
Q2 		$2.58M Buy
232,016
+49,717
+27% +$622K ﹤0.01% 2842
2025
Q1 		$2.24M Sell
182,299
-2,548
-1% -$31.9K ﹤0.01% 2859
2024
Q4 		$2.07M Buy
184,847
+25,035
+16% +$218K ﹤0.01% 3006
2024
Q3 		$1.11M Buy
159,812
+117,647
+279% +$860K ﹤0.01% 3315
2024
Q2 		$319K Buy
42,165
+12,571
+42% +$127K ﹤0.01% 3673
2024
Q1 		$391K Sell
29,594
-5,428
-15% -$77.4K ﹤0.01% 3645
2023
Q4 		$361K Buy
35,022
+12,821
+58% +$102K ﹤0.01% 3661
2023
Q3 		$216K Buy
22,201
+6,095
+38% +$35.7K ﹤0.01% 3783
2023
Q2 		$72.3K Sell
16,106
-65
-0.4% -$294 ﹤0.01% 4125
2023
Q1 		$75K Hold
16,171
– – ﹤0.01% 4154
2022
Q4 		$24.1K Hold
16,171
– – ﹤0.01% 4451
2022
Q3 		$61K Buy
16,171
+4,896
+43% +$23.6K ﹤0.01% 4271
2022
Q2 		$56K Sell
11,275
-48,909
-81% -$323K ﹤0.01% 4375
2022
Q1 		$494K Sell
60,184
-4,343
-7% -$37.5K ﹤0.01% 3747
2021
Q4 		$650K Sell
64,527
-852
-1% -$11.1K ﹤0.01% 3711
2021
Q3 		$1.04M Sell
65,379
-5,898
-8% -$124K ﹤0.01% 3541
2021
Q2 		$1.7M Buy
+71,277
New +$1.65M ﹤0.01% 3399

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Northern Trust's NPCE Position: Q2 2026 in Review

Northern Trust increased its Neuropace (NPCE) stake by 8.4% in Q2 2026, buying an estimated $325K and bringing the position to 260,025 shares worth $4.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2725.

Northern Trust first reported a position in NPCE in Q2 2021 and has held it in 21 quarters since. 113 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • Northern Trust held 260,025 shares of Neuropace worth $4.13M as of Q2 2026.
  • Northern Trust bought 20,185 Neuropace shares in Q2 2026, an estimated $325K.
  • Neuropace made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2725 holding.
  • Northern Trust first reported a position in Neuropace in Q2 2021 and has held it in 21 quarters since.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.